TETRACAINE HYDROCHLORIDE

NDA 208135 · New Drug Application (NDA) Prescription

TETRACAINE HYDROCHLORIDE

Sponsor (Drugs@FDA)
ALCON LABS Company: ALCON INC (ALC)
First approved
Latest action

Drugs on HealthTrade

No drug on HealthTrade cites this application. Novel approvals since 2015 by healthcare companies HealthTrade covers are listed from Drugs@FDA automatically, labelled “Not yet reviewed”; editors link the others.

Products

Drugs@FDA products under NDA 208135, with Orange Book listing details
ProductName and ingredientForm and strengthMarketing statusTE codeReferenceOrange Book
001 TETRACAINE HYDROCHLORIDE TETRACAINE HYDROCHLORIDE SOLUTION;OPHTHALMIC 0.5%Prescription– Reference listed drug, Reference standard RXApproved

Submissions

FDA submissions for NDA 208135, newest first
SubmissionStatusStatus dateReviewClassDocuments
Supplement 5ApprovedstandardLabelingLetter for Supplement 5 (opens in a new tab)Label for Supplement 5 (opens in a new tab)
Original 1ApprovedstandardType 7 - Drug Already Marketed without Approved NDALetter for Original 1 (opens in a new tab)Label for Original 1 (opens in a new tab)

Orange Book patents

No Orange Book patents are listed for this application.

Orange Book exclusivities

No Orange Book exclusivities are listed for this application.

Prescription labels

The latest version of each DailyMed label, newest first. Indications and boxed warnings are cut to 1,000 characters; DailyMed has the full label.

  • Tetracaine Hydrochloride

    TETRACAINE HYDROCHLORIDE · REMEDYREPACK INC. · OPHTHALMIC · Version 3 · effective

    Indications and usage

    1 INDICATIONS AND USAGE Tetracaine Hydrochloride Ophthalmic Solution 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. Tetracaine Hydrochloride Ophthalmic Solution 0.5% is an ester local anesthetic indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. ( 1 )

    Full label on DailyMed for Tetracaine Hydrochloride (opens in a new tab)

  • Tetracaine Hydrochloride

    TETRACAINE HYDROCHLORIDE · A-S Medication Solutions · OPHTHALMIC · Version 9 · effective

    Indications and usage

    1 INDICATIONS AND USAGE Tetracaine Hydrochloride Ophthalmic Solution 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. Tetracaine Hydrochloride Ophthalmic Solution 0.5% is an ester local anesthetic indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. ( 1 )

    Full label on DailyMed for Tetracaine Hydrochloride (opens in a new tab)

  • Tetracaine Hydrochloride

    TETRACAINE HYDROCHLORIDE · Alcon Laboratories, Inc. · OPHTHALMIC · Version 14 · effective

    Indications and usage

    1 INDICATIONS AND USAGE Tetracaine Hydrochloride Ophthalmic Solution 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. Tetracaine Hydrochloride Ophthalmic Solution 0.5% is an ester local anesthetic indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. ( 1 )

    Full label on DailyMed for Tetracaine Hydrochloride (opens in a new tab)

NDC products

3 products in the NDC directory with this application number.

NDC directory products for NDA 208135
Product NDCNameLabelerForm and routeCategoryMarketing dates
0065-0741 in openFDA (opens in a new tab) Tetracaine Hydrochloride tetracaine hydrochlorideAlcon Laboratories, Inc. SOLUTION OPHTHALMICNDA From
50090-2364 in openFDA (opens in a new tab) Tetracaine Hydrochloride tetracaine hydrochlorideA-S Medication Solutions SOLUTION OPHTHALMICNDA From
70518-4183 in openFDA (opens in a new tab) Tetracaine Hydrochloride tetracaine hydrochlorideREMEDYREPACK INC. SOLUTION OPHTHALMICNDA From

FDA recalls load here.

FDA drug shortages load here.

Sources

Data provided by the U.S. Food and Drug Administration. Showing it here is not an FDA endorsement. openFDA asks: “Do not rely on openFDA to make decisions regarding medical care.”

Patent and exclusivity dates are as FDA lists them and can change. Nothing on this page is medical or investment advice.